Roche Gets Food and Drug Administration OK for Improved HIV Test

Now Live: Breaking Research From XVII International AIDS Conference >>

U.S. Centers for Disease Control and Prevention • News Briefs

April 11, 2003

More on HIV Testing

Swiss manufacturer Roche Holding AG said Friday the US Food and Drug Administration has cleared an improved test to measure viral levels in the blood of HIV/AIDS patients. The test is designed to amplify and detect genetic material, allowing for the accurate measurement of even small amounts of virus. "The Cobas Amplicor HIV-1 Monitor Test (version 1.5) will allow laboratories to delivery quality HIV viral load tests in a shorter time, thanks to cutting edge automation," said Heino von Prondzynski, head of Roche Diagnostics.

Back to other CDC news for April 11, 2003

Previous Updates | Search the CDC archive

Excerpted from:
Reuters
04.11.03

This article was provided by U.S. Centers for Disease Control and Prevention, and is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.

The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.